VTRS Form 3: Andrew Enrietti Discloses Shares, Options and RSU Vesting Schedules

Rhea-AI Filing Summary

Viatris Inc. (VTRS) Form 3 reports that Andrew Enrietti, identified as an officer and director-level executive (Chief Administrative and Transformation Officer), beneficially owns 130,000 shares of common stock directly and holds multiple employee equity awards. The filing lists vested stock options exercisable between 2026 and 2030 covering 11,697 options and several restricted stock unit grants and dividend equivalent units totaling 99,237 underlying shares scheduled to vest on specified dates between 2026 and 2028.

Positive

• Direct beneficial ownership of 130,000 shares reported, indicating alignment of the officer with shareholder interests
• Detailed vesting schedules for RSUs and options provide transparency on future potential share issuances and timing
• Presence of vested options (exercisable beginning 07/18/2026) shows portions of compensation already earned

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine Section 16 disclosure showing officer ownership and standard equity grants; no governance red flags.

The Form 3 is an initial beneficial ownership statement for an executive officer. It discloses direct ownership of 130,000 shares and multiple equity awards with defined vesting schedules and exercise prices. From a governance perspective, the filing documents customary compensation-related holdings and contains the required power-of-attorney signature. There is no indication of related-party transactions or unusual arrangements in the disclosed items.

Compensation Analyst

TL;DR: Disclosure shows a mix of vested options and multi-year RSU vesting — typical long-term incentive structure.

The schedule lists vested employee stock options with exercise prices from $17.48 to $45.53 and RSU grants with staggered vesting through 2028. Dividend equivalent units accompany RSU awards and vest on the same schedules. These elements align with common long-term retention incentives used in executive pay programs and clarify the officer's potential equity dilution and timing of future share issuance upon vesting or exercise.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Enrietti Andrew

(Last) (First) (Middle)

1000 MYLAN BOULEVARD

(Street)

CANONSBURG PA 15317

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2025

3. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	130,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option - Right to Buy	(1)	07/18/2026	Common Stock	4,531	$45.53	D
Employee Stock Option - Right to Buy	(2)	03/03/2027	Common Stock	1,305	$45.18	D
Employee Stock Option - Right to Buy	(3)	03/02/2028	Common Stock	1,773	$40.97	D
Employee Stock Option - Right to Buy	(4)	03/01/2029	Common Stock	1,409	$27.45	D
Employee Stock Option - Right to Buy	(5)	03/02/2030	Common Stock	2,679	$17.48	D
Restricted Stock Units	(6)	(6)	Common Stock	11,531	$0	D
Dividend Equivalent Units	(7)	(7)	Common Stock	1,411.47	$0	D
Restricted Stock Units	(8)	(8)	Common Stock	27,137	$0	D
Dividend Equivalent Units	(9)	(9)	Common Stock	1,890.95	$0	D
Restricted Stock Units	(10)	(10)	Common Stock	57,506	$0	D
Dividend Equivalent Units	(11)	(11)	Common Stock	1,502.1407	$0	D

Explanation of Responses:

1. These options vested on July 18, 2020.

2. These options vested on March 3, 2020.

3. These options vested on March 2, 2021.

4. These options vested on March 2, 2022.

5. These options vested on March 2, 2023.

6. Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs granted on March 3, 2023 will vest on March 3, 2026.

7. Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs granted on March 3, 2023 and vest on the same schedule as the underlying RSUs.

8. Each RSU represents the right to receive one share of common stock of Viatris. 13,568 of the RSUs granted on March 4, 2024 will vest on March 4, 2026 and 13,569 will vest on March 4, 2027.

9. Represents DEUs that accrued with respect to the RSUs granted on March 4, 2024 and vest on the same schedule as the underlying RSUs.

10. Each RSU represents the right to receive one share of common stock of Viatris. 19,169 of the RSUs granted on March 6, 2025 will vest on March 6, 2026, 19,168 will vest on March 6, 2027, and 19,169 will vest on March 6, 2028.

11. Represents DEUs that accrued with respect to the RSUs granted on March 6, 2025 and vest on the same schedule as the underlying RSUs.

Remarks:

Chief Administrative and Transformation Officer, Exhibit 24 - Power of Attorney

	/s/ Kevin D. Macikowski, by power of attorney	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for VTRS disclose about Andrew Enrietti's holdings?

The filing shows 130,000 shares owned directly and multiple employee stock options and restricted stock units with specified vesting dates and exercise prices.

How many shares underlying RSUs and DEUs are disclosed on the VTRS Form 3?

The Form 3 lists RSUs and associated dividend equivalent units totaling 99,237 underlying common shares scheduled to vest on dates between 2026 and 2028.

Are any of the reported stock options already vested for the reporting person on the VTRS Form 3?

Yes. Several options are listed as vested (with exercise dates shown); the earliest exercisable date in the filing is 07/18/2026.

What is the reporting person's role at Viatris as stated in the Form 3?

The filing identifies the reporting person as the Chief Administrative and Transformation Officer (role noted in the remarks).